IL-33, IL-25, and ECP Levels were Decreased in Severe Persistent Allergic Asthma Patients with the Anti-IgE (Omalizumab) Treatment

Atıf

Paylaş

Oral Presentation

P: 236 - 236

Nisan 2019

Turk Thorac J 2019;20(1):236-236

1. Internal Medicine, Allergy and Clinical Immunology, Academia Sinica, Genomics Research Center, Taipei, Taiwan

2. Health Sciences University, Antalya Trainig and Research Hospital, Antalya, Turkey

Bilgi mevcut değil.

Bilgi mevcut değil

Kabul Tarihi: 07.08.2019

Online Tarih: 07.08.2019

Yayın Tarihi: 07.08.2019

Atıf

Paylaş